Chemotherapy plus progenitor autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy26

Hematopoietic Stem Cells Stem Cells Bone Marrow Bone Marrow Cells Cells, Cultured Myeloid Progenitor Cells Neural Stem Cells T-Lymphocytes Lymphoid Progenitor Cells Fetal Blood Multipotent Stem Cells Erythroid Precursor Cells Endothelial Cells Mesenchymal Stromal Cells Liver Clone Cells Granulocytes Adult Stem Cells Embryonic Stem Cells Transplants Cell Line, Tumor Antilymphocyte Serum Neoplastic Stem Cells Blood Cells Lymphocytes Neurons

Organisms8

Transplantation Chimera Mice, Inbred C57BL Lentivirus Rabbits Mice, Transgenic Mice, SCID Mice, Inbred BALB C Mice, Knockout

Diseases42

Multiple Myeloma Lymphoma, Non-Hodgkin Hodgkin Disease Recurrence Graft vs Host Disease Neoplasm Recurrence, Local Hematologic Neoplasms Breast Neoplasms Lung Neoplasms Lymphoma Leukemia, Myeloid, Acute Neoplasm, Residual Leukemia Neoplasm Metastasis Myelodysplastic Syndromes Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Lymphoma, Large B-Cell, Diffuse Disease Progression Neoplasms Postoperative Complications Liver Failure Carcinoma, Squamous Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Neutropenia Acute Disease Leukemia, Myeloid Liver Neoplasms Disease Models, Animal Carcinoma, Small Cell Hematologic Diseases Cadaver Liver Diseases Ovarian Neoplasms Testicular Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Anemia, Aplastic Adenocarcinoma Thrombocytopenia Brain Neoplasms Nausea Vomiting

Chemicals and Drugs55

Cyclophosphamide Melphalan Etoposide Granulocyte Colony-Stimulating Factor Antigens, CD34 Doxorubicin Vincristine Antineoplastic Agents Cisplatin Carmustine Prednisone Cytarabine Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Murine-Derived Antibodies, Monoclonal Busulfan Methotrexate Immunosuppressive Agents Bleomycin Organoplatinum Compounds Carboplatin Antineoplastic Agents, Alkylating Fluorouracil Myeloablative Agonists Thalidomide Vinblastine Kanamycin Kinase Mechlorethamine Dexamethasone Idarubicin Antigens, CD Procarbazine Epirubicin Recombinant Proteins Ifosfamide Thiotepa Paclitaxel Leucovorin Cyclosporine Taxoids Tacrolimus Antimetabolites, Antineoplastic Deoxycytidine HLA Antigens Biological Markers Granulocyte-Macrophage Colony-Stimulating Factor Mitoxantrone Anthracyclines Stem Cell Factor Erythropoietin Antineoplastic Agents, Phytogenic Antilymphocyte Serum Antigens, Neoplasm Green Fluorescent Proteins Interleukin-3

Analytical, Diagnostic and Therapeutic Techniques and Equipment92

Transplantation, Autologous Antineoplastic Combined Chemotherapy Protocols Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Combined Modality Therapy Liver Transplantation Transplantation Conditioning Treatment Outcome Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Chemotherapy, Adjuvant Disease-Free Survival Kidney Transplantation Survival Analysis Salvage Therapy Peripheral Blood Stem Cell Transplantation Survival Rate Cell Transplantation Remission Induction Heart Transplantation Bone Marrow Purging Prognosis Leukapheresis Lung Transplantation Follow-Up Studies Whole-Body Irradiation Retrospective Studies Lymphatic Irradiation Colony-Forming Units Assay Organ Transplantation Neoplasm Staging Blood Transfusion, Autologous Neoadjuvant Therapy Prospective Studies Pancreas Transplantation Islets of Langerhans Transplantation Cell Separation Transplantation Feasibility Studies Radiotherapy Flow Cytometry Blood Component Removal Kaplan-Meier Estimate Blood Cell Count Cell Culture Techniques Transplantation, Isogeneic Genetic Therapy Cord Blood Stem Cell Transplantation Immunomagnetic Separation Transplantation, Heterotopic Transduction, Genetic Drug Administration Schedule Clinical Trials as Topic Heart-Lung Transplantation Multivariate Analysis Transplantation, Heterologous Immunosuppression Histocompatibility Testing Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Skin Transplantation Tissue Transplantation Induction Chemotherapy Immunohistochemistry Polymerase Chain Reaction Risk Factors Cell Count Corneal Transplantation Actuarial Analysis Brain Tissue Transplantation Disease Models, Animal Immunophenotyping Neoplasm Transplantation Fatal Outcome Reverse Transcriptase Polymerase Chain Reaction Leukocyte Count Patient Selection Organ Preservation Donor Selection Infusions, Intravenous Immunotherapy Coculture Techniques Lymphocyte Activation Lymphocyte Culture Test, Mixed Facial Transplantation Pilot Projects Radiotherapy, Adjuvant Chemotherapy, Cancer, Regional Perfusion Proportional Hazards Models Biopsy Postoperative Period

Phenomena and Processes30

Graft Survival Time Factors Cell Differentiation Hematopoiesis Graft Rejection Transplantation Immunology Graft vs Tumor Effect Blood Cell Count Cell Lineage Genetic Vectors Transduction, Genetic Cell Proliferation Transplantation Tolerance Histocompatibility Cell Division Cell Survival Drug Resistance, Neoplasm Cell Count Regeneration Dose-Response Relationship, Drug Apoptosis Signal Transduction Cell Movement Phenotype Neurogenesis Gene Expression Regulation, Developmental Leukocyte Count Lymphocyte Activation Cytotoxicity, Immunologic Neovascularization, Physiologic

Disciplines and Occupations1

Immunohistochemistry

Information Science2

Survival Rate Fatal Outcome

Named Groups2

Tissue Donors Living Donors

Health Care22

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Prospective Studies Feasibility Studies Kaplan-Meier Estimate Clinical Trials as Topic Multivariate Analysis Tissue and Organ Procurement Risk Factors Waiting Lists Actuarial Analysis Fatal Outcome Patient Selection Donor Selection Pilot Projects Age Factors Proportional Hazards Models Postoperative Period

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Transplantation, Autologous Antineoplastic Combined Chemotherapy Protocols Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Combined Modality Therapy Liver Transplantation Transplantation Conditioning Cyclophosphamide Treatment Outcome Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Multiple Myeloma Chemotherapy, Adjuvant Disease-Free Survival Hematopoietic Stem Cells Melphalan Etoposide Kidney Transplantation Granulocyte Colony-Stimulating Factor Survival Analysis Salvage Therapy Antigens, CD34 Doxorubicin Graft Survival Peripheral Blood Stem Cell Transplantation Stem Cells Vincristine Lymphoma, Non-Hodgkin Hodgkin Disease Antineoplastic Agents Survival Rate Cell Transplantation Remission Induction Cisplatin Carmustine Recurrence Heart Transplantation Bone Marrow Purging Prognosis Leukapheresis Lung Transplantation Follow-Up Studies Whole-Body Irradiation Time Factors Retrospective Studies Graft vs Host Disease Cell Differentiation Prednisone Cytarabine Antibodies, Monoclonal, Humanized Lymphatic Irradiation Bone Marrow Neoplasm Recurrence, Local Antibodies, Monoclonal, Murine-Derived Bone Marrow Cells Antibodies, Monoclonal Busulfan Colony-Forming Units Assay Hematopoiesis Cells, Cultured Hematologic Neoplasms Organ Transplantation Neoplasm Staging Breast Neoplasms Blood Transfusion, Autologous Methotrexate Immunosuppressive Agents Neoadjuvant Therapy Graft Rejection Lung Neoplasms Bleomycin Prospective Studies Organoplatinum Compounds Carboplatin Pancreas Transplantation Tissue Donors Antineoplastic Agents, Alkylating Islets of Langerhans Transplantation Cell Separation Transplantation Immunology Fluorouracil Transplantation Myeloablative Agonists Feasibility Studies Graft vs Tumor Effect Transplantation Chimera Lymphoma Thalidomide Vinblastine Leukemia, Myeloid, Acute Radiotherapy Flow Cytometry Neoplasm, Residual Blood Component Removal Kanamycin Kinase Leukemia Mechlorethamine Kaplan-Meier Estimate Blood Cell Count

No FAQ available that match "chemotherapy plus progenitor autologous transplantation"